Another study reported that RPA1 was increased in both liver cancer cell lines and HCC tissues and promoted the proliferation of HCC via the cyclin-dependent-kinase 4(CDK4)/cyclin-D pathway (Wang et al. 2018c). This evidence concerns the gene RPA1 and hepatocellular carcinoma.